261 related articles for article (PubMed ID: 23831208)
21. Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes.
Badolo L; Trancart MM; Gustavsson L; Chesné C
Chem Biol Interact; 2011 Apr; 190(2-3):165-70. PubMed ID: 21356203
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
23. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
24. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
25. High affinity of 4-(4-(dimethylamino)styryl)-N-methylpyridinium transport for assessing organic cation drugs in hepatocellular carcinoma cells.
Jinakote M; Ontawong A; Soodvilai S; Pimta J; Pasachan T; Chatsudthipong V; Srimaroeng C
Fundam Clin Pharmacol; 2020 Jun; 34(3):365-379. PubMed ID: 31883148
[TBL] [Abstract][Full Text] [Related]
26. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
[TBL] [Abstract][Full Text] [Related]
27. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.
Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG
Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869
[TBL] [Abstract][Full Text] [Related]
28. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Zhang L; Schaner ME; Giacomini KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
[TBL] [Abstract][Full Text] [Related]
30. Modes of cell death in rat liver after monocrotaline exposure.
Copple BL; Rondelli CM; Maddox JF; Hoglen NC; Ganey PE; Roth RA
Toxicol Sci; 2004 Jan; 77(1):172-82. PubMed ID: 14600277
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
32. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
Dresser MJ; Gray AT; Giacomini KM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1146-52. PubMed ID: 10688634
[TBL] [Abstract][Full Text] [Related]
33. Involvement of human organic cation transporter 1 in the hepatic uptake of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel, small molecule survivin suppressant.
Iwai M; Minematsu T; Narikawa S; Usui T; Kamimura H
Drug Metab Dispos; 2009 Sep; 37(9):1856-63. PubMed ID: 19520775
[TBL] [Abstract][Full Text] [Related]
34. Sitagliptin attenuates metformin-mediated AMPK phosphorylation through inhibition of organic cation transporters.
Choi MK; Jin QR; Ahn SH; Bae MA; Song IS
Xenobiotica; 2010 Dec; 40(12):817-25. PubMed ID: 20863201
[TBL] [Abstract][Full Text] [Related]
35. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha.
Saborowski M; Kullak-Ublick GA; Eloranta JJ
J Pharmacol Exp Ther; 2006 May; 317(2):778-85. PubMed ID: 16436500
[TBL] [Abstract][Full Text] [Related]
36. The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1.
Saadatmand AR; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
Biochem Pharmacol; 2012 May; 83(10):1427-34. PubMed ID: 22342776
[TBL] [Abstract][Full Text] [Related]
37. Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.
Ahlin G; Chen L; Lazorova L; Chen Y; Ianculescu AG; Davis RL; Giacomini KM; Artursson P
Pharmacogenomics J; 2011 Dec; 11(6):400-11. PubMed ID: 20567254
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine.
Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570
[TBL] [Abstract][Full Text] [Related]
39. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
[TBL] [Abstract][Full Text] [Related]
40. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1.
Martel F; Vetter T; Russ H; Gründemann D; Azevedo I; Koepsell H; Schömig E
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):320-6. PubMed ID: 8878062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
